Does carnosic acid ( CA ) prevent lipid accumulation in hepatocytes through the EGFR/MAPK pathway?
EGFR/MAPK signaling plays an important role in the inhibitory effect of CA on hepatocyte lipid accumulation.
The potent CCK-1R antagonist devazepide increases susceptibility to gallstone formation by impairing gallbladder emptying function, disrupting biliary cholesterol metabolism and enhancing intestinal cholesterol absorption in mice.